PMVP

NASDAQStock

PMV Pharmaceuticals, Inc.

$1.55-0.03 (-1.58%)

52-Week Range

$0.84

$1.80

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.27

Volume

451.8K

Avg Volume

1.6M

Performance

+46.30%

+31.67%

+38.60%

YTD

+28.46%

+25.40%

-71.53%

-96.07%

Price Chart

ETF Exposure

PMVP is held by 10 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PQSG	PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF	0.18%	833	$23K	$13.0M	—
IWC	iShares Micro-Cap ETF	0.02%	123,240	$197K	$1.27B	0.60%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	4,716	$8K	$803.1M	0.23%
VXF	Vanguard Extended Market ETF	0.00%	409,910	$443K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	73	$107	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,612	$4K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	12	$18	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,487,065	$1.6M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	7,821	$11K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	674	$986	$1.29B	0.17%

About PMVP ETF Exposure

PMV Pharmaceuticals, Inc. (PMVP) is held by 10 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $1.55. Investors can gain exposure to PMVP through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PMVP, sorted by portfolio weight.